Compare SKYE & SURG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SKYE | SURG |
|---|---|---|
| Founded | 2012 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Advertising |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.4M | 6.4M |
| IPO Year | 2013 | 2019 |
| Metric | SKYE | SURG |
|---|---|---|
| Price | $1.18 | $0.14 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $68.00 | N/A |
| AVG Volume (30 Days) | 98.4K | ★ 3.2M |
| Earning Date | 11-24-2026 | 11-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 24.69 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $56,962,920.00 |
| Revenue This Year | N/A | $14.11 |
| Revenue Next Year | N/A | $23.23 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.26 | $0.11 |
| 52 Week High | $11.68 | $2.08 |
| Indicator | SKYE | SURG |
|---|---|---|
| Relative Strength Index (RSI) | 44.62 | 46.56 |
| Support Level | $0.26 | $0.14 |
| Resistance Level | $1.66 | $0.18 |
| Average True Range (ATR) | 0.20 | 0.02 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 62.05 | 30.46 |
Skye Bioscience Inc is a pre-clinical pharmaceutical company located in San Diego, California. The company's clinical assets focus on the modulation of cannabinoid receptor 1 ("CB1") to provide novel treatments and alternatives for diseases caused by metabolic disorders, inflammation, fibrosis, and neurodegeneration, such as obesity and glaucoma. The company's Phase 2 clinical candidates include nimacimab, a negative allosteric modulating antibody that inhibits peripheral CB1 receptors, currently being developed for the treatment of obesity and SBI-100 Ophthalmic Emulsion ("SBI-100 OE"), a CB1 agonist (activator), currently being developed for the treatment of glaucoma and ocular hypertension.
Surgepays Inc is a wireless and point of sale technology company focused on serving underserved and value-conscious consumers through a combination of retail distribution and digital acquisition channels. It provides mobile connectivity, financial technology services, and transaction processing solutions through an integrated platform that combines wireless services with point of sale software and retail distribution. It enables in-store and online activation of wireless services, prepaid top-ups, and financial transactions, allowing consumers to access essential services in both local and digital environments. Its segments are wireless services or MVNO Telecommunications, platform services or MVNE Enablement Platform (HERO), and wholesale enablement or Comprehensive Platform Services.